In contrast, some studies reported that GLI1 and SHH can be positively stained in a large percentage of NSCLC samples (> 85%), and a subset of NSCLC cell lines were sensitive to HH inhibitors [18, 19]. The gene discussed is SHH; the disease is non-small cell lung carcinoma.